World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Zhuang L, You J, Tang BZ, Ding SY, Yan KH, Peng D, Zhang YM, Zhang L. Preliminary results of Thymosin-a1 vs interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B. World J Gastroenterol 2001; 7(3): 407-410 [PMID: 11819800 DOI: 10.3748/wjg.v7.i3.407]
URL:	https://www.wjgnet.com/1007-9327/full/v7/i3/407.htm

(0) (0) (0) (4439) (28)

Number	Citing Articles
1	A. Ciancio, M. Rizzetto. Thymalfasin in the treatment of hepatitis B and C. Annals of the New York Academy of Sciences 2010; 1194(1) doi: 10.1111/j.1749-6632.2010.05487.x
2	S. Iino, J. Toyota, H. Kumada, K. Kiyosawa, S. Kakumu, M. Sata, H. Suzuki, E. B. Martins. The efficacy and safety of thymosin alpha‐1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. Journal of Viral Hepatitis 2005; 12(3) doi: 10.1111/j.1365-2893.2005.00633.x
3	C. Trépo, F. Zoulim. Traitement de l’hépatite B : progrès attendus. Gastroentérologie Clinique et Biologique 2009; 33(8-9) doi: 10.1016/j.gcb.2009.04.005
4	Xiaoning Wu, Jidong Jia, Hong You. Thymosin alpha-1 treatment in chronic hepatitis B. Expert Opinion on Biological Therapy 2015; 15(sup1) doi: 10.1517/14712598.2015.1007948
5	Hong-Lei Han, Zhen-Wei Lang. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment. World Journal of Gastroenterology 2003; 9(1): 117-121 doi: 10.3748/wjg.v9.i1.117 Abstract(1265) \| Core Tip(1112) \| Full Article(HTML)(2811) \| Full Article (PDF)-477K(597) \| Times Cited (13) \| Total Visits (4532) \| Open
6	Stephanos J Hadziyannis, George V Papatheodoridis. Emerging treatments in chronic hepatitis B. Expert Opinion on Emerging Drugs 2004; 9(2) doi: 10.1517/14728214.9.2.207
7	Bo Hyun Kim, Youn-Jae Lee, Won Kim, Jung-Hwan Yoon, Eun Uk Jung, Sung Jae Park, Yoon Jun Kim, Hyo-Suk Lee. Efficacy of thymosin α-1 plus peginterferon α-2a combination therapy compared with peginterferon α-2a monotherapy in HBeAg-positive chronic hepatitis B: A prospective, multicenter, randomized, open-label study. Scandinavian Journal of Gastroenterology 2012; 47(8-9) doi: 10.3109/00365521.2012.694902
8	Haipeng Zhu, Ke Wang, Wei Du, Huanhuan Cao, Qingyang Zhong, Sichun Yin, Jianbo Zhong, Fawu Li. H3K9 acetylation modification and TLR9 immune regulation mechanism in patients after anti-HBV treatment. Medicine 2022; 101(52) doi: 10.1097/MD.0000000000032431
9	WANHU FAN, JUN CHENG, SHULIN ZHANG, XIAOJING LIU. Cloning and functions of the HBxAg-binding protein XBP1. Molecular Medicine Reports 2013; 7(2) doi: 10.3892/mmr.2012.1232
10	Ying Chen, Johnny Sze, Ming-Liang He. HBV cccDNA in patients’ sera as an indicator for HBV reactivation and an early signal of liver damage. World Journal of Gastroenterology 2004; 10(1): 82-85 doi: 10.3748/wjg.v10.i1.82 Abstract(1640) \| Core Tip(1402) \| Full Article(HTML)(4420) \| Full Article (PDF)-97K(641) \| Times Cited (44) \| Total Visits (6155) \| Open
11	Yu-Hu Song, Ju-Sheng Lin, Nan-Zhi Liu, Xin-Juan Kong, Na Xie, Nan-Xia Wang, You-Xin Jin, Kuo-Huan Liang. Anti-HBV hairpin ribozyme-mediated cleavage of target RNA <italic>in vitro</italic>. World Journal of Gastroenterology 2002; 8(1): 91-94 doi: 10.3748/wjg.v8.i1.91 Abstract(1679) \| Core Tip(1087) \| Full Article(HTML)(3410) \| Full Article (PDF)-125K(443) \| Times Cited (10) \| Total Visits (4393) \| Open
12	Expert Consensus on the Clinical Application of Thymosin Alpha 1 in Infectious Diseases and Critical Care Medicine. Infectious Microbes and Diseases 2025; 7(2) doi: 10.1097/IM9.0000000000000176
13	ENRICO GARACI, CARTESIO FAVALLI, FRANCESCA PICA, PAOLA SINIBALDI VALLEBONA, ANNA TERESA PALAMARA, CLAUDIA MATTEUCCI, PASQUALE PIERIMARCHI, ANNALUCIA SERAFINO, ANTONIO MASTINO, FRANCESCO BISTONI, LUIGINA ROMANI, GUIDO RASI. Thymosin Alpha 1. Annals of the New York Academy of Sciences 2007; 1112(1) doi: 10.1196/annals.1415.044
14	Yong-Feng Yang, Wei Zhao, Yan-Dan Zhong, Yi-Jun Yang, Ling Shen, Ning Zhang, Ping Huang. Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis. Antiviral Research 2008; 77(2) doi: 10.1016/j.antiviral.2007.10.014
15	Raymund R. Razonable, James M. McGill. Hepatitis Prevention and Treatment. 2004; doi: 10.1007/978-3-0348-7903-3_10
16	Chun-Hong Ma, Wen-Sheng Sun, Pei-Kun Tian, Li-Fen Gao, Su-Xia Liu, Xiao-Yan Wang, Li-Ning Zhang, Ying-Lin Cao, Li-Hui Han, Xiao-Hong Liang. A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(3): 463-467 doi: 10.3748/wjg.v9.i3.463 Abstract(1375) \| Core Tip(1216) \| Full Article(HTML)(3102) \| Full Article (PDF)-141K(614) \| Times Cited (5) \| Total Visits (4254) \| Open
17	Cho Naing, Han Ni, Htar Htar Aung, Saint Nway Aye, Dimitrinka Nikolova, Yong Poovorawan, Chavdar Pavlov. Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database of Systematic Reviews 2026; 2026(9) doi: 10.1002/14651858.CD014610.pub2
18	Yui-Jie Bai, Jin-Rong Zhao, Guan-Ting Lv, Wen-Hong Zhang, Yan Wang, Xiao-Jun Yan. Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization. World Journal of Gastroenterology 2003; 9(10): 2344-2347 doi: 10.3748/wjg.v9.i10.2344 Abstract(1512) \| Core Tip(1280) \| Full Article(HTML)(3946) \| Full Article (PDF)-109K(767) \| Times Cited (15) \| Total Visits (5669) \| Open
19	Xiao-Ju Guan, Xiao-Jun Guan, Yu-Zhang Wu, Zheng-Cai Jia, Tong-Dong Shi, Yan Tang. Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine. World Journal of Gastroenterology 2002; 8(2): 294-297 doi: 10.3748/wjg.v8.i2.294 Abstract(1494) \| Core Tip(1343) \| Full Article(HTML)(3045) \| Full Article (PDF)-130K(510) \| Times Cited (10) \| Total Visits (4544) \| Open
20	YUN‐FAN LIAW. Thymalfasin (thymosin‐alpha 1) therapy in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2004; 19(S6) doi: 10.1111/j.1440-1746.2004.03633.x
21	Roberto Camerini, Enrico Garaci. Historical review of thymosin α 1 in infectious diseases. Expert Opinion on Biological Therapy 2015; 15(sup1) doi: 10.1517/14712598.2015.1033393
22	Murat Saruc, Nuri Ozden, Nurten Turkel, Semin Ayhan, Lynette M. Hock, Isil Tuzcuoglu, Hakan Yuceyar. Long-term outcomes of thymosin-α1 and interferon α-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B. Journal of Pharmaceutical Sciences 2003; 92(7) doi: 10.1002/jps.10401
23	Jin Ding, Jun Liu, Cai-Fang Xue, Wei-Dong Gong, Ying-Hui Li, Ya Zhao. Anti-HBV effect of TAT- HBV targeted ribonuclease. World Journal of Gastroenterology 2003; 9(7): 1525-1528 doi: 10.3748/wjg.v9.i7.1525 Abstract(1334) \| Core Tip(1084) \| Full Article(HTML)(3192) \| Full Article (PDF)-350K(652) \| Times Cited (6) \| Total Visits (4356) \| Open
24	Guo-Liang Zhang, Ye-Hong Wang, Wei Ni, Hui-Ling Teng, Zhi-Bin Lin. Hepatoprotective role of <italic>ganoderma lucidum</italic> polysaccharide against BCG-induced immune liver injury in mice. World Journal of Gastroenterology 2002; 8(4): 728-733 doi: 10.3748/wjg.v8.i4.728 Abstract(1663) \| Core Tip(1304) \| Full Article(HTML)(6475) \| Full Article (PDF)-1303K(855) \| Times Cited (75) \| Total Visits (8396) \| Open
25	Rong-Nan Chien, Yun-Fan Liaw. Thymalfasin for the treatment of chronic hepatitis B. Expert Review of Anti-infective Therapy 2004; 2(1) doi: 10.1586/14787210.2.1.9
26	Zheng-Wen Liu, Qun-Ying Han, Ni Zhang, Wen Kang. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World Journal of Gastroenterology 2004; 10(7): 972-976 doi: 10.3748/wjg.v10.i7.972 Abstract(1447) \| Core Tip(1344) \| Full Article(HTML)(3009) \| Full Article (PDF)-125K(464) \| Times Cited (6) \| Total Visits (4578) \| Open
27	R‐N. Chien, C‐Y. Lin, C‐T. Yeh, Y‐F. Liaw. Hepatitis B virus genotype B is associated with better response to thymosin α1 therapy than genotype C. Journal of Viral Hepatitis 2006; 13(12) doi: 10.1111/j.1365-2893.2006.00761.x